news, latest-news, allergies, allergy, anaphylaxis, food allergies, allergy inquiry, immunology
Those living with life-threatening allergies are being forced to wait up to more than a year just to receive treatment, with experts saying wait times are set to get even worse. As the number of adults being diagnosed with anaphylaxis increases, immunologists and allergy specialists are reporting they are often unable to keep up with demand for testing and treatment. Allergy and Anaphylaxis Australia chief executive Maria Said said allergy sufferers seeking a diagnosis and specialist testing from immunologists are being put at risk due to the increased wait times. "When you have a life-threatening reaction, it could be between 12 and 18 months before an appointment, and that's really unacceptable considering the impact that allergic diseases have on people's quality of life," Ms Said said. "This has the potential to be a lot worse." A study from the Australian Society of Clinical Immunology and Allergy found 10 per cent of infants, up to 8 per cent of children and 2 per cent of adults reported having some form of food-related allergy. A National Health Survey from 2015 also found 3.1 per cent of Australians reported an "undefined allergy", with other forms of anaphylaxis including exposure to mould, insect bites or latex. Ms Said said increased wait times were being seen across Australia, with even longer wait times out of the major capital cities. A spokeswoman for Canberra Health Services said data on average wait times to see ACT-based immunologists was not collected. "Immunologists also deal with patients with other conditions, including serious autoimmune and inflammatory diseases and immune deficiencies," the spokeswoman said. "As a result, there is considerable demand for appointments. There are six immunologists employed by Canberra Health Services, all with part-time appointments." Canberra immunologist Dr Raymond Mullins said while wait times vary from state to state, public hospital outpatient waiting lists are normally more than 12 months. "Food allergies and anaphylaxis have moved from a marginal phenomena to an ongoing public health issue for an increasing proportion of the population and their caregivers," Dr Mullins said. "This has implications in terms of cost of care, the need for medical visits and review, the use and availability of emergency medication such as EpiPens." While data from the ACT is not available, figures from Victoria showed a median waiting time of more than 100 days to access immunologists for allergy testing. Dr Mullins said more people were in need of seeing immunologists as children who developed allergies got older. "Young children who have nut allergies will generally still have persistent food allergy 80 per cent time," he said. "That means we have an ageing population of teenagers and young adults with persistent food allergy at greater risk of having more serious reactions including fatalities." Ms Said said as more adults were experiencing severe allergies, many immunology clinics have been unable to keep up with demand, with many clinics only specialising in paediatrics. "There's only a handful of public clinics, and most are specifically for children, yet there's a growing number of adults with allergic diseases," she said. "It's very concerning because allergic diseases can't be cured and it has to be managed, and people need to be educated on how it can be managed." READ MORE: The access to treatment for those with anaphylaxis forms part of a federal government inquiry into severe allergies. In its submission to the inquiry, the federal Health Department said Australia had one of the highest rates of allergies and anaphylaxis in the world. "Available evidence from hospital admissions for anaphylaxis indicates the prevalence has increased in many western countries, including Australia," the department said. "Total hospital admissions rates for all causes of anaphylaxis increased by 8 per cent each year between 1997 and 2013." The Australian Society of Clinical Immunology and Allergy has told the inquiry the current access process for immunology testing was time-consuming and complicated, calling for access to be simplified. Ms Said said more public clinics were needed in order to reduce wait times for those with anaphylaxis. "We need them especially in rural and remote areas to allow for greater access to an accurate diagnosis and accurate information on allergy management," she said.
SUBSCRIBER
November 18 2019 - 4:30AM
Those living with life-threatening allergies are being forced to wait up to more than a year just to receive treatment, with experts saying wait times are set to get even worse.
As the number of adults being diagnosed with anaphylaxis increases, immunologists and allergy specialists are reporting they are often unable to keep up with demand for testing and treatment.
Allergy and anaphylaxis patients are being forced to wait months to see public immunologists and specialists. Picture: Elesa Kurtz
Allergy and Anaphylaxis Australia chief executive Maria Said said allergy sufferers seeking a diagnosis and specialist testing from immunologists are being put at risk due to the increased wait times.
"When you have a life-threatening reaction, it could be between 12 and 18 months before an appointment, and that's really unacceptable considering the impact that allergic diseases have on people's quality of life," Ms Said said.
"This has the potential to be a lot worse."
A study from the Australian Society of Clinical Immunology and Allergy found 10 per cent of infants, up to 8 per cent of children and 2 per cent of adults reported having some form of food-related allergy.
A National Health Survey from 2015 also found 3.1 per cent of Australians reported an "undefined allergy", with other forms of anaphylaxis including exposure to mould, insect bites or latex.
Ms Said said increased wait times were being seen across Australia, with even longer wait times out of the major capital cities.
Food allergies have shifted from being a fringe issue to a major public health concern. Picture: Shutterstock
A spokeswoman for Canberra Health Services said data on average wait times to see ACT-based immunologists was not collected.
"Immunologists also deal with patients with other conditions, including serious autoimmune and inflammatory diseases and immune deficiencies," the spokeswoman said.
"As a result, there is considerable demand for appointments. There are six immunologists employed by Canberra Health Services, all with part-time appointments."
Canberra immunologist Dr Raymond Mullins said while wait times vary from state to state, public hospital outpatient waiting lists are normally more than 12 months.
"Food allergies and anaphylaxis have moved from a marginal phenomena to an ongoing public health issue for an increasing proportion of the population and their caregivers," Dr Mullins said.
"This has implications in terms of cost of care, the need for medical visits and review, the use and availability of emergency medication such as EpiPens."
The availability of EpiPens is now a core health concern for public institutions. Picture: Shutterstock
While data from the ACT is not available, figures from Victoria showed a median waiting time of more than 100 days to access immunologists for allergy testing.
Dr Mullins said more people were in need of seeing immunologists as children who developed allergies got older.
"Young children who have nut allergies will generally still have persistent food allergy 80 per cent time," he said.
"That means we have an ageing population of teenagers and young adults with persistent food allergy at greater risk of having more serious reactions including fatalities."
Ms Said said as more adults were experiencing severe allergies, many immunology clinics have been unable to keep up with demand, with many clinics only specialising in paediatrics.
"There's only a handful of public clinics, and most are specifically for children, yet there's a growing number of adults with allergic diseases," she said.
"It's very concerning because allergic diseases can't be cured and it has to be managed, and people need to be educated on how it can be managed."
The access to treatment for those with anaphylaxis forms part of a federal government inquiry into severe allergies.
In its submission to the inquiry, the federal Health Department said Australia had one of the highest rates of allergies and anaphylaxis in the world.
"Available evidence from hospital admissions for anaphylaxis indicates the prevalence has increased in many western countries, including Australia," the department said.
"Total hospital admissions rates for all causes of anaphylaxis increased by 8 per cent each year between 1997 and 2013."
The Australian Society of Clinical Immunology and Allergy has told the inquiry the current access process for immunology testing was time-consuming and complicated, calling for access to be simplified.
Ms Said said more public clinics were needed in order to reduce wait times for those with anaphylaxis.
"We need them especially in rural and remote areas to allow for greater access to an accurate diagnosis and accurate information on allergy management," she said.
Here is the original post:
Anaphylaxis patients forced to wait more than a year for testing - The Canberra Times
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]
- Smoking has long-term effects on the immune system - Institut Pasteur - February 21st, 2024 [February 21st, 2024]
- Spring Allergies Attack More Than Just Your Nose - ACAAI Public Website - American College of Allergy Asthma and Immunology - February 21st, 2024 [February 21st, 2024]
- Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Shikhar Mehrotra named co-leader of Cancer Biology and Immunology research program at MUSC Hollings - The Cancer Letter - January 27th, 2024 [January 27th, 2024]
- Gut Microbiome Benefits of Breast Milk Revealed in Mouse Study - Technology Networks - January 27th, 2024 [January 27th, 2024]
- Research on Immunological Diseases Launches with Hungarian Participation - Hungary Today - January 27th, 2024 [January 27th, 2024]
- UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Associated Press - January 8th, 2024 [January 8th, 2024]
- TRexBio Announces a First Option Was Exercised by Partner under Immunology Discovery Collaboration - Business Wire - January 8th, 2024 [January 8th, 2024]
- UCLA to turn former Westside Pavilion into centers for research on immunology and quantum science - KABC-TV - January 8th, 2024 [January 8th, 2024]
- HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases - PR Newswire - January 8th, 2024 [January 8th, 2024]
- Beyond Cytotoxicity: The Importance of T Cell Memory - The Scientist - January 8th, 2024 [January 8th, 2024]
- IKAROS: Unlocking the secrets of the immune system's key player - News-Medical.Net - January 8th, 2024 [January 8th, 2024]
- UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Caledonian-Record - January 8th, 2024 [January 8th, 2024]
- Revolutionizing Vaccine Research: The Power of a New Algorithm - SciTechDaily - December 31st, 2023 [December 31st, 2023]
- Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people ... - Nature.com - December 22nd, 2023 [December 22nd, 2023]
- Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis - News-Medical.Net - December 22nd, 2023 [December 22nd, 2023]
- Physician and Patient (Un)Wellness in Allergy and Immunology During COVID-19 and Beyond: Lessons for the Future - Physician's Weekly - December 22nd, 2023 [December 22nd, 2023]
- Researchers Identify Why Some Cancers Do Not Respond to Immunotherapy - NYU Langone Health - December 22nd, 2023 [December 22nd, 2023]
- MU's Haval Shirwan recognized for achievements in immunology - Columbia Daily Tribune - December 22nd, 2023 [December 22nd, 2023]